Dena Esfandyari
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cardiac Fibrosis and Remodeling
Papers in
-
- Cardiac Fibrosis and Remodeling 3
-
- MicroRNA in disease regulation 2
- Co-authors
- Deepak Prabhu Ramanujam (3 shared papers)Stefan Hanns Engelhardt (4 shared papers)Regalla Kumarswamy (1 shared paper)Bart De Strooper (1 shared paper)Manuel Mayr (1 shared paper)Petros Avramopoulos (2 shared papers)Stanislas Werfel (2 shared papers)Bernhard Laggerbauer (2 shared papers)
- Journals
- Nature Communications (3 papers)eLife (2 papers)JHEP Reports (1 paper)Science (1 paper)Circulation (1 paper)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Dena Esfandyari
8 papers receiving 498 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 143
- Cardiology and Cardiovascular Medicine 155
- Immunology 79
- Molecular Biology 257
- Endocrine and Autonomic Systems 19
Countries citing papers authored by Dena Esfandyari
This map shows the geographic impact of Dena Esfandyari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dena Esfandyari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dena Esfandyari more than expected).
Fields of papers citing papers by Dena Esfandyari
This network shows the impact of papers produced by Dena Esfandyari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dena Esfandyari. The network helps show where Dena Esfandyari may publish in the future.
Co-authors
The 25 scholars most cited alongside Dena Esfandyari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 196 | |
| 2 | 2021 | 121 | |
| 3 | 2020 | 67 | |
| 4 | 2023 | 58 | |
| 5 | 2022 | 26 | |
| 6 | 2024 | 18 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 0 | |
| 10 | 2026 | 0 |
About Dena Esfandyari
Dena Esfandyari is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research, Immunology, Surgery and Endocrine and Autonomic Systems, having authored 10 papers that have together received 503 indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (3 papers), MicroRNA in disease regulation (2 papers), Signaling Pathways in Disease (2 papers), Cardiac Structural Anomalies and Repair (2 papers), Neuroscience of respiration and sleep (1 paper), Animal Virus Infections Studies (1 paper), RNA modifications and cancer (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Cancer Research (143 citations), Cardiology and Cardiovascular Medicine (155 citations), Immunology (79 citations), Molecular Biology (257 citations) and Endocrine and Autonomic Systems (19 citations). Dena Esfandyari has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Deepak Prabhu Ramanujam, Stefan Hanns Engelhardt, Regalla Kumarswamy, Bart De Strooper, Manuel Mayr, Petros Avramopoulos, Stanislas Werfel, Bernhard Laggerbauer, Andreas‐David Brunner and Yassine Sassi. Their work appears in journals such as Nature Communications, eLife, JHEP Reports, Science and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.